Companies – Potsdam Science Park

5.5.22

»The most important thing is: talk about your ideas, don’t keep quiet« – A Conversation with Johannes Zier from the International Start-up Service at the University of Potsdam

With over 25 years of experience supporting startups, 300 of them nurtured over the last 10 years alone, and ranked 3rd in Startup Radar 2021, Potsdam Transfer’s Start-up Service is one of Germany’s most successful. In this interview we hear from its head of, Johannes Zier, on how he and the team got to this…

24.2.22

3 Questions to Biotx.ai: „With our AI platform, we have achieved something in three months that previously took the industry several years to do“

Artificial intelligence is one of the big trending topics of our time. But what exactly can it do? Biotx.ai, a company based in the Potsdam Science Park, manages to recognize complex patterns in genomic data with its AI platform, enabling it to make precise predictions about the efficacy of new therapies. Their approach could radically…

17.2.22

3 questions to biocyc – „With our new antibody production process, we are one of the few companies in the world that are able to do this“

In a way, biocyc is one of the hidden champions of the Potsdam Science Park. Producing peptides for both the pharmaceutical industry and research as well as antibodies for cancer diagnostics, their success allows them to build their own production building in the Potsdam Science Park. In our interview, biocyc CEO Alexander Gorczyza talks about…

3.2.22

3 questions to Porous – „Quantitative ultrasound technology allows the early detection of osteoporosis.”

Osteoporosis effects billions of people worldwide and creates economic costs of about 60 billion US Dollars annually. Until recently, the early diagnosis of the disorder with conventional means has been nearly impossible. The MedTech startup Porous GmbH, a spin-off of Charité Berlin, is planning to change that. In our interview, CEO Bart Hendriks tells us…

13.1.22

3 Questions to QMEDIS – „We are working on the 2D printing of drugs“

Starting in January 2022, new companies and research groups will move into the newly built H-LAB in the Potsdam Science Park. Among them will be QMEDIS Analytics, a contract lab where drugs are not only analysed but also produced. In our interview, Dr. Dennis Stracke explains how the lab works and how drug printers could…

6.1.22

3 Questions to GILUPI – „We think our way of diagnosing cancer cells is ground-breaking“.

Scientists around the world are researching ways for a better treatment of cancer. One of them is offered by GILUPI, a company founded in 2006. With their product, medical personnel can extract cancer cells from the blood. Dr. Christian Jurinke has been the company’s CEO since 2018. In our interview, he explains why good diagnostics…